Abstract |
A series of gold(I) complexes involving triphenylphosphine (PPh3) and one N-donor ligand derived from deprotonated mono- or disubstituted hypoxanthine (HLn) of the general composition [Au(Ln)(PPh3)] (1-9) is reported. The complexes were thoroughly characterized, including multinuclear high resolution NMR spectroscopy as well as single crystal X-ray analysis (for complexes 1 and 3). The complexes were screened for their in vitro cytotoxicity against human cancer cell lines MCF7 ( breast carcinoma), HOS ( osteosarcoma) and THP-1 (monocytic leukaemia), which identified the complexes 4-6 as the most promising representatives, who antiproliferative activity was further tested against A549 ( lung adenocarcinoma), G-361 ( melanoma), HeLa ( cervical cancer), A2780 (ovarian carcinoma), A2780R (ovarian carcinoma resistant to cisplatin), 22Rv1 ( prostate cancer) cell lines. Complexes 4-6 showed a significantly higher in vitro anticancer effect against the employed cancer cells, except for G-361, as compared with the commercially used anticancer drug cisplatin, with IC50 ≈ 1-30 µM. Anti-inflammatory activity was evaluated in vitro by the assessment of the ability of the complexes to modulate secretion of the pro-inflammatory cytokines, i.e. tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), in the lipopolysaccharide-activated macrophage-like THP-1 cell model. The results of this study identified the complexes as auspicious anti-inflammatory agents with similar or better activity as compared with the clinically applied gold-based antiarthritic drug Auranofin. In an effort to explore the possible mechanisms responsible for the biological effect, the products of interactions of selected complexes with sulfur-containing biomolecules ( L-cysteine and reduced glutathione) were studied by means of the mass-spectrometry study.
|
Authors | Radka Křikavová, Jan Hošek, Ján Vančo, Jakub Hutyra, Zdeněk Dvořák, Zdeněk Trávníček |
Journal | PloS one
(PLoS One)
Vol. 9
Issue 9
Pg. e107373
( 2014)
ISSN: 1932-6203 [Electronic] United States |
PMID | 25226034
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Organophosphorus Compounds
- triphenylphosphine
- Hypoxanthine
- Gold
|
Topics |
- Anti-Inflammatory Agents
(chemistry, pharmacology, toxicity)
- Antineoplastic Agents
(chemistry, pharmacology, toxicity)
- Cell Line
- Cell Line, Tumor
- Gold
(chemistry)
- Humans
- Hypoxanthine
(chemistry, pharmacology, toxicity)
- Macrophages
(drug effects, metabolism)
- Models, Molecular
- Molecular Conformation
- Molecular Structure
- Nuclear Magnetic Resonance, Biomolecular
- Organophosphorus Compounds
(chemistry, pharmacology, toxicity)
|